鹭燕医药：控股股东麦迪肯解除质押2252.38万股股

Core Viewpoint - The announcement indicates that the controlling shareholder, Xiamen Maidiken Technology Co., Ltd., has released a pledge on 22,523,834 shares of Luyan Pharmaceutical, representing 16.32% of its holdings and 5.80% of the company's total share capital [1] Summary by Relevant Sections - Share Pledge Release - Xiamen Maidiken has released a pledge on 22,523,834 shares, effective from November 2, 2020, to October 31, 2025 [1] - Shareholding Structure - As of the announcement date, Maidiken holds 138,030,674 shares, which is 35.53% of the total share capital, with no shares currently pledged [1] - The total shares held by Maidiken and its concerted parties amount to 147,775,681 shares, representing 38.04% of the total share capital, with no pledged shares [1]